Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure (Q74708419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Doron Aronson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 September 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

297-301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

Advances in coronary angioplasty

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Effectiveness of percutaneous coronary interventions to prevent recurrent coronary events in patients on chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

The comparative pathobiology of atherosclerosis and restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Pathology of Acute and Chronic Coronary Stenting in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Restenosis revisited--new targets, new therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

The restenosis paradigm revisited: an alternative proposal for cellular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

RAGE: a novel cellular receptor for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900172-X

7 January 2021

10.1016/S0306-9877(02)00172-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12208156%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference